Tiernan McDonough named PSA AMH Aged Care Pharmacist of the Year

30 May 2026

 

The Pharmaceutical Society of Australia (PSA) has presented Tiernan McDonough MPS as the 2026 PSA AMH Aged Care Pharmacist of the Year during the Consultant Pharmacist Conference (CPC26). 

 

Sponsored by the Australian Medicines Handbook (AMH), an evidence-based, independent publisher of key national medicines references including the AMH Aged Care Companion, the Aged Care Pharmacist of the Year award recognises excellence, leadership, and innovation in aged care pharmacy. 

 

Based in South Australia, Mr McDonough has been recognised for his ongoing dedication and commitment to aged care pharmacy practice through his support of residents and healthcare teams in his delivery of medication reviews and quality use of medicines services.  

 

PSA National President, Professor Mark Naunton MPS, said Mr McDonough embodies the essnetial role pharmacists play in aged care.  

 

“Pharmacists working in aged care are critical to ensuring the safe and effective medicines use, but Tiernan’s impact extends beyond the aged care sector in which he practices,” he said.  

 

“Tiernan has led an important mentoring program that connects pharmacists within the residential aged care profession, to reduce professional isolation and support further workforce development.  

 

“His work demonstrates his compassion, leadership, and a strong drive for improving care for older Australians.”  

 

The PSA extends its congratulations to Tiernan McDonough MPS on being named PSA AMH Aged Care Pharmacist of the Year for 2026 and thanks AMH for again supporting the Aged Care Pharmacist of the Year award at CPC.  

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Kelly Abbott awarded PSA MIMS Consultant Pharmacist of the Year

29 May 2026

 

The Pharmaceutical Society of Australia (PSA) has named Kelly Abbott MPS as the PSA MIMS Consultant Pharmacist of the Year. 

 

Presented this evening at the Consultant Pharmacist Conference (CPC26) on the Gold Coast, Ms Abbott has been recognised for her outstanding contribution to consultant pharmacy practice and passion for improving patient care throughout her hometown of Gippsland, Victoria.  

 

Highly regarded across the industry for her work in delivering Home Medicines Reviews, Residential Medication Management Reviews, and providing Quality Use of Medicines services, Ms Abbott’s 15 years of service to consultant pharmacy make her a well-deserving winner of this year’s award.  

 

PSA National President, Professor Mark Naunton MPS, said Ms Abbott epitomises many credentialed pharmacists as a passionate and relentless advocate for HMRs, her patients, and the greater credentialed pharmacist workforce.  

 

“Kelly has continued to be actively involved in grassroots advocacy, notably in recent months during the First Pharmacy Programs Agreement negotiations led by PSA, ensuring the voices of frontline pharmacists and patients were heard,” he said.  

 

“Kelly is a loyal, responsive, and reliable contributor to PSA and the Consultant Pharmacist of Australia working groups, while balancing multiple professional roles and caring for her family. 

 

“Her contributions to PSA and the profession are honourable. We are proud to recognise Kelly as the PSA MIMS Consultant Pharmacist of the Year and celebrate her significant and ongoing impact.”  

 

The PSA congratulates Kelly Abbott MPS on this well-deserved recognition and thank MIMS Australia for their continued support of the Consultant Pharmacist of the Year award.  

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Integrated care in focus as health leaders back pharmacists in general practice

28 May 2026

 

Four of Australia’s leading health peak bodies have united in calling for investment in general practice pharmacists to make medicine use safer and strengthen multidisciplinary care.

 

Speaking at an inter-professional panel session at its 2026 GP Pharmacist Symposium today on the Gold Coast, presidents from the Pharmaceutical Society of Australia, Australian Medical Association, Royal Australian College of General Practitioners, and Australian Primary Health Care Nurses Association reinforced the clinical need and value of embedding pharmacists within general practice.

 

The session provided a real-life demonstration of cohesion, bringing together representatives from general practice, medicine, nursing, and pharmacy.

 

Exploring how collaborative healthcare efforts can improve patient care, reduce pressure on hospitals, and strengthen the primary care workforce, the panel was made up of extraordinary leaders, including:  

 

• Tracey Johnson – CEO, Inala Primary Care 

• Denise Lyons – President, Australian Primary Health Care Nurses Association 

• Dr Danielle McMullen – President, Australian Medical Association 

• Professor Mark Naunton – President, Pharmaceutical Society of Australia 

• Dr Michael Wright – President, The Royal Australian College of General Practitioners  

 

 

PSA National President, Professor Mark Naunton MPS, reinforced the importance of having pharmacists wherever medicines are.

 

“Pharmacists working in general practice settings offer additional protections that enhance medicines safety and improve patient outcomes,” he said.  

 

“The organisations are united in working together to ensure patients receive safe, efficient, and reliable healthcare across the entire patient journey.”  

 

 

AMA President, Dr Danielle McMullan, said strengthening multidisciplinary care in general practice is key to improving outcomes and system sustainability. 

 

“Pharmacists are experts in medications, including medication interactions, and embedding pharmacists in general practice makes a lot of sense. We would see better outcomes for patients through improved medication management,” she said.  

 

“Previous research commissioned by the AMA highlighted that every $1 invested in supporting this type of role would generate $1.56 in savings to the health system.” 

 

 

RACGP President, Dr Michael Wright, said integrating pharmacists into general practice benefits patients, clinicians, and the broader health system. 

 

“Embedding pharmacists in general practice makes sense for patients, policymakers, GPs, and pharmacists themselves. 

 

“GPs and practices recognise the value general practice-based pharmacists can provide for patients and the health system by preventing unnecessary hospitalisations and readmissions. There’s real goodwill and mutual respect for the services and education pharmacists can provide as a member of a general practice team. 

 

“Long-term, targeted funding for general practice-based pharmacists through the Workforce Incentive Program would break the biggest barrier to more practices adding a pharmacist to their team, and is an important shared priority for the RACGP and PSA.” 

 

 

APNA President, Denise Lyons, said funding reform must support genuinely integrated, team-based care across the primary health system.   

 

“We strongly support funding reform that enables more integrated, multidisciplinary care, bringing together nurses, pharmacists, GPs and other health professionals to work as one team around the patient,” she said.  

 

“To truly strengthen primary care, we need national, coordinated action that supports all healthcare professionals to work to their full scope in connected, team-based models.” 

 

 

The organisations are committed to working together to improve patient care, reduce pressure on the hospital system, and strengthen the primary care workforce.  

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA announces 2026 Faye McMillan Conference Grant recipients

27 May 2026

 

The Pharmaceutical Society of Australia (PSA) has marked the beginning of National Reconciliation Week by announcing the recipients of the 2026 PSA Faye McMillan Conference Grant.  

 

Returning for the fourth consecutive year, the PSA Faye McMillan Conference Grant supports Aboriginal and or Torres Strait Islander pharmacists, interns, and or pharmacy students to attend PSA’s national annual conference. 

 

Professor Faye McMillan AM FPS is a Wiradjuri yinaa (Wiradjuri woman) originally from Trangie, NSW, and is recognised as the first Indigenous Australian to hold a Western degree in pharmacy. 

 

The PSA has committed to supporting the workforce participation of First Nations Australians across the pharmacy profession and is proud to honour Professor Faye McMillan AM FPS in this way.   

 

Sponsored this year by Camurus, alongside Care Pharmaceuticals and Hydralyte, the PSA are pleased to announce the recipients of the 2026 PSA Faye McMillan Conference Grant are: 

 

• Eliza Brown 

• Caleb Foster 

• Penny May 

 

 

PSA/NACCHO Aboriginal and Torres Strait Islander Pharmacy Practice Community of Specialty Interest Chair, Ms Chastina Heck MPS, said the return of the PSA Faye McMillan Conference Grant supports PSA’s commitment to empowering the next generation of First Nations pharmacists.  

 

“This empowerment starts with creating a sense of belonging within the pharmacy profession and is an essential early step in growing our First Nations workforce,” she said.  

 

“The legacy of the Faye McMillan grant reflects the importance of facilitating relationships based on authenticity and creating that welcoming environment.” 

 

 

A spokesperson for Camurus Pty Ltd said: 

 

“Camurus is proud to support the PSA Faye McMillan Conference Grant and help strengthen opportunities for First Nations pharmacists. 

 

“Supporting Indigenous leadership and representation in healthcare is essential to improving outcomes for communities across Australia. 

 

“We wish the recipients and the PSA a successful PSA2026 conference.”  

 

 

A spokesperson for Care Pharmaceuticals and Hydralyte said:  

 

“Care Pharmaceuticals is proud to continue supporting the PSA Faye McMillan Conference Grant, which recognises the outstanding contributions of Indigenous pharmacists, including Professor Faye McMillan, in advancing equitable healthcare for Aboriginal and Torres Strait Islander communities. 

 

“Through this partnership, Care Pharmaceuticals and Hydralyte reaffirm our commitment to fostering diversity and inclusion within the pharmacy profession and supporting culturally safe healthcare for all Australians. 

 

“Now in our third year of supporting this important initiative, we are delighted to continue our partnership with PSA and remain committed to contributing to the ongoing success of the program.”  

 

 

More information about the 2026 PSA Faye McMillan Conference Grant is available here: https://www.psa.org.au/the-psa-faye-mcmillan-conference-grant-returns-for-a-fourth-consecutive-year/.  

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA welcomes expansion of FluMist program for NSW children

27 May 2026

 

The Pharmaceutical Society of Australia (PSA) has today welcomed the New South Wales Government’s expansion of the funded FluMist Nasal Spray Influenza Vaccination Program to improve access to the influenza vaccine for children aged 2-17.  

 

From Wednesday 27 May, the total doses available under the Nasal Spray Influenza Vaccination Program will increase from 8,000 to 11,000. 

 

PSA NSW President, Luke Kelly FPS, said the expansion is a step in the right direction to improving vaccination accessibility, particularly for young families.  

 

“With Winter coming up, now is the time to get vaccinated against influenza,” he said.  

 

“Having alternative vaccination methods is a positive move that we expect will improve child and adolescent vaccination rates this year.  

 

“I encourage parents to talk to their pharmacist to see which vaccination method is most suitable for their child or children ahead of the 2026 flu season.”  

 

The PSA acknowledges that pharmacists are well placed to deliver vaccinations safely and conveniently and will continue to advocate for expanded pharmacist-delivered vaccination services.  

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Tasmanian budget delivers crucial investment to take pharmacist-led care to the next level

21 May 2026

 

The Pharmaceutical Society of Australia (PSA) has welcomed investments that will strengthen access to pharmacist-led care, delivered today by the Treasurer, the Hon. Eric Abetz, in the 2026-27 Tasmanian State Budget. 

 

The 2026-27 Tasmanian State Budget has outlined: 

• $1 million to fund scholarships for more pharmacists to undertake expanded scope of practice training,  

• $1 million in funding for community pharmacy grants – with up to $125,000 per pharmacy to support access to after-hours care, and 

• $20 million over four years to The Health Revolution: 20-Year Preventative Health Strategy.  

 

PSA Tasmanian Branch President, Joanne Gross MPS, said PSA has long been advocating for pharmacist scholarships to support the growing role of pharmacists in Australia’s healthcare system.  

 

“Pharmacists play a crucial role as one of Australia’s most accessible healthcare professionals, particularly in rural and regional centres, which makes these investments so important in expanding the range of services we can provide for our patients,” she said. 

 

“This is a practical step forward which will improve access to timely assessment and treatments for many patients. As more pharmacists undertake prescribing training, patients will have greater access to treatments for conditions such as ear infections and urinary tract infections, alongside access to hormonal contraception.”  

 

Ms Gross also welcomed support for greater after-hours pharmacist care: 

 

“Healthcare doesn’t stop at the end of the working day. Patients still need access to healthcare after hours, which is why we’re so pleased to welcome grants that expand access to after-hours pharmacy care.”

 

The PSA commends the Tasmanian Government on these initiatives and looks forward to working alongside them to deliver safer, more accessible healthcare for Tasmanians.

 

The PSA is currently taking enrolments for Tasmanian pharmacists in our Graduate Certificate in Pharmacist Prescribing course. More information is available here.  

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA welcomes expansion of needle-free flu vaccine for QLD children and adolescents

19 May 2026

 

The Pharmaceutical Society of Australia (PSA) has welcomed the Queensland Government’s decision to expand the needle-free influenza vaccination program for those aged 6 to under 18 who struggle with needles.

 

The expansion builds on the 2026 Queensland Free Flu Vaccination Program and the Queensland Nasal Spray Flu Immunisation Program, which currently provides free needle-free influenza vaccines for children 2-5.

 

PSA QLD President, Hannah Knowles MPS, said extending eligibility for FluMist would remove significant barriers to vaccination and improve overall protection against influenza in QLD.

 

“For many families, it is a real challenge to ensure our children are protected against illness, such as influenza, particularly with so many children having an aversion to needles,” she said.

 

“This fear of needles presents a genuine vaccination barrier, and so the expansion of free access to FluMist for more children and adolescents will significantly increase QLD’s vaccination rates.

 

“Community pharmacies are well placed to support children and families in being protected against influenza, particularly now with the expanded access to those who may have otherwise avoided vaccination.”

 

The PSA applauds the practical and patient-centred steps taken by the QLD government to make vaccination easier for patients and encourages QLD families to speak with their pharmacist to determine the most appropriate influenza vaccination option this flu season.

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au 

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.  

All in for culturally safe care: Pharmacists urged to strengthen delivery of the PBS Closing the Gap Co payment Program

18 May 2026

JOINT MEDIA RELEASE

 

The Pharmaceutical Society of Australia (PSA), in collaboration with Advanced Pharmacy Australia (AdPha), the National Aboriginal Community Controlled Health Organisation (NACCHO), and the Pharmacy Guild of Australia (the Guild), is calling on pharmacists and pharmacy staff to strengthen their commitment to delivering culturally safe care when supporting Aboriginal and Torres Strait Islander peoples through the Closing the Gap (CTG) PBS Co-payment Program.

 

With support from the pharmacy sector, the PSA is hosting a webinar during National Reconciliation Week to assist all pharmacy staff in navigating and strengthening the CTG PBS co-payment Program.

 

The National Reconciliation Week theme, ‘All in for Reconciliation,’ provides a timely opportunity for pharmacy organisations and NACCHO to come together and recognise that improving First Nations health outcomes is a shared responsibility.

 

 

PSA National President, Professor Mark Naunton MPS, said the CTG PBS Co-payment Program plays a vital role in improving access to affordable medicines for Aboriginal and Torres Strait Islander peoples.

 

“The CTG PBS Co-payment Program provides the opportunity to close the gap in health outcomes faced by First Nations Australians and foster equitable access to medicines,” he said.

 

“Wherever you practice, whether you’re a pharmacy assistant, technician, student, intern, or pharmacist, you play a role in ensuring First Nations peoples receive care that is considered culturally safe, respectful, and responsive. I encourage you to get involved and attend the upcoming webinar.”

 

 

Mike Stephens, NACCHO’s Director of Medicines Policy and Programs, emphasised the importance of developing and delivering culturally safe models of care.

 

“It’s incredibly important that people feel safe when accessing CTG prescriptions, but we know this hasn’t always been the experience,” he said.

 

“PSA’s webinar provides a great opportunity for pharmacists to nurture strong, community-level relationships by thinking about how and where conversations about the CTG PBS Co-payment Program are conducted, and what systems are in place to support these communities.

 

“We need all pharmacy staff to get involved, ensure the Program delivers the outcomes it intends to, and ensure Aboriginal and Torres Strait Islander peoples receive culturally safe care.”

 

 

AdPha President, Associate Professor Tom Simpson, said that with funding now available to expand the CTG PBS Co-payment Program, the focus must now shift to consistent, culturally safe implementation across hospital and primary care settings.

 

“We are proud to work collaboratively across the pharmacy sector to support stronger access to medicines for Aboriginal and Torres Strait Islander peoples,” he said.

 

“After years of advocacy to improve equity between primary and acute care, it is critical that this program is implemented in a way that supports patients seamlessly as they move through the health system and ensures culturally safe care remains at the centre of every interaction.”

 

 

The Guild’s First Nations Pharmacy Network Chair, Linda Burney, noted:

 

“Through the CTG PBS Co-payment Program, community pharmacy teams help reduce cost barriers and support continuity of care for First Nations people.

 

“Delivering the program effectively requires culturally responsive practice, clear communication, and strong local relationships.

 

“The Guild is pleased to support this webinar and encourage pharmacy staff to continue building their understanding and confidence to provide care that meets the needs of First Nations communities.”

 

 

The PSA, AdPha, NACCHO, and the Guild are united in their commitment to ensuring Aboriginal and Torres Strait Islander peoples receive high-quality, culturally safe care wherever they access pharmacy services.

 

The webinar, Stories that Drive Change: Pharmacy’s role in Closing the Gap, will take place on Wednesday 27 May from 7.00-8.15 pm, on the first night of National Reconciliation Week.

 

Register here: https://psa-org-au.zoom.us/webinar/register/WN_70bmGfXNSIq2-PNOZDFNsQ.

 

 

 

Media contacts

Leah Jacobsen M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

Patients at risk as the Federal Budget keeps medicine safety frozen in the previous decade

12 May 2026

 

The Pharmaceutical Society of Australia (PSA), the peak body for Australia’s 41,000 pharmacists, has expressed its disappointment with the outcome of the 2026-27 Federal Budget, leaving one of Australia’s top ten national health priorities stuck in the last decade.

 

The Budget has failed to deliver urgent and overdue investment in pharmacist-led medicine safety programs, continuing to leave thousands of pharmacists in financially unviable positions and placing Australians at risk of harm from preventable hospitalisations, medical emergencies, and premature death.

 

PSA National President, Professor Mark Naunton MPS, said the outcome was incredibly frustrating, particularly for vulnerable Australians living with chronic and complex conditions, the elderly, and those in residential care and more acutely felt in rural, remote and regional Australia.

 

“Pharmacists provide frontline patient care, delivering essential medicines safety services every single day to keep people well and out of hospital,” said Professor Naunton.

 

“The Federal Government acknowledges medicine safety as a top ten health priority, yet this Budget continues to neglect these programs, which have now been frozen for seven years. 

 

“The First Pharmacy Program Agreement Heads of Agreement secured these medicine safety programs and workforce programs as ongoing programs. But without funding to address the key issues of indexation, the removal of service caps, and program flexibility, these programs, which are predominantly delivered by women, will continue to widen the gender pay gap for these pharmacists.”

 

Despite the proposals put forward to the government in PSA’s Budget Submission, which included seeking progress on the Heads of Agreement for the First Pharmacy Program Agreement signed last December, there is:

• no funding to reinstate indexation for pharmacist service fees, which have been frozen since 2019, meaning credentialed pharmacists are taking a pay cut each year,
• no change to the monthly cap of 30 Home Medicines Reviews (HMRs), meaning patients will continue to languish on waiting lists, including those who require urgent intervention
• no reform on any flexibility measures to help pharmacists care for vulnerable Australians promptly and effectively,
• and no change to key medication management programs.

 

Professor Naunton called on the government to address this funding shortfall and fast-track the signing of the First Pharmacy Programs Agreement:

 

“The 1PPA recognises the need to ensure fair and equitable remuneration for pharmacists and to remove barriers to effective service delivery,” he said.

 

“The PSA remains determined to negotiate with the government on this, as it is critical to achieve reform of pharmacy program design and service delivery.

 

“We will not sign a pharmacy programs agreement until we have a pathway to addressing fair remuneration and flexibility”.

 

The PSA recognises and welcomes the government’s $41.2 million commitment in the Budget to the expansion of the National Immunisation Program Vaccinations in Pharmacy (NIPVIP) Program, which will allow, for the first time, children under the age of 5 years to access free vaccination services in pharmacy, where permitted by state and territory regulation.

 

“This measure will unlock the potential of pharmacists to do more to help address the declining rates of childhood vaccination in Australia.” Prof Naunton concluded.

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system. 

PSA welcomes expanded scope of practice for NT

12 May 2026

 

The Pharmaceutical Society of Australia (PSA) has applauded the Finocchiaro government’s announcement to expand the scope of practice for Northern Territory (NT) pharmacists.  

 

Patients in the Northern Territory will be able to visit participating local pharmacies where trained pharmacists can assess, diagnose, and manage or treat 21 common conditions, where clinically appropriate.  

 

2025 PSA Symbion Pharmacist of the Year, Jaimee Anderson MPS, who lives and works in Katherine, NT, has warmly welcomed the announcement.  

 

“This has the potential to streamline services and provide access, particularly during the tourist season, when demand outnumbers the capacity of primary health services,” she said.  

 

“We know that the tourist season sees a rise in the number of people needing healthcare services. Pharmacist prescribing can and will reduce the burden on GPs during periods of increasing demand.  

 

“This announcement is the right move for the NT and is sure to be well received by patients, healthcare professionals, and travellers.”  

 

PSA National President, Professor Mark Naunton MPS, said the announcement is a step forward for pharmacists to deliver frontline health care.  

 

“People living in the Northern Territory will be able to receive treatment, advice, and medicines from appropriately trained local pharmacists for a number of common health conditions,” said Professor Naunton.  

 

“We expect this to ease the pressure on primary health networks, reduce hospital presentations, and support the Territory’s health system overall. 

 

“We look forward to working with the Northern Territory government and pharmacists to ensure patients continue to receive safe, high-quality healthcare.”  

 

The PSA’s Pharmacist Prescribing Scope of Practice Training Program is now taking enrolments, with eligible pharmacists able to access a training subsidy of up to $8,500 for successful completion of the course. 

 

Further information regarding PSA’s Pharmacist Prescribing Scope of Practice Program can be found here: https://www.psa.org.au/pharmacist-prescribing-scope-of-practice-training-program/#1764307925514-bf27e406-fd28 

 

More information following the announced changes in the NT can be accessed here: https://findapharmacy.com.au/nt-services 

 

 

 

Media contact: Leah Jacobsen 

M: 0480 099 798 E: leah.jacobsen@psa.org.au  

The Pharmaceutical Society of Australia is the only national peak body that represents all of Australia’s pharmacists across all practice settings. We want every Australian to have access to the best healthcare, and this must include optimising access to pharmacists’ knowledge and medicines expertise at the forefront of our healthcare system.